XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
B
B

BayerAG

뉴스

Reuters - 1 일 전

BASF hopes pricing power will boost profit growth later in the year

UPDATE 3-BASF hopes pricing power will boost profit growth later in the year Adds CEO comment in paragraphs 2-4, shares in paragraph 6 By Ludwig Burger FRANKFURT, July 26 (Reuters) - BASF BASFn.DE is banking on regaining pricing power to speed up earnings growth in the second half after the German chemicals group's adjusted profit edged 0.6% higher in the second quarter, with China playing a key role.
B
B
G
Reuters - 2 일 전

Bayer's Monsanto to pay $160 mln to resolve Seattle's PCB contamination lawsuit

Bayer's Monsanto to pay $160 mln to resolve Seattle's PCB contamination lawsuit By Jonathan Stempel July 25 (Reuters) - Monsanto will pay $160 million to settle a lawsuit by the city of Seattle that accused the unit of Germany's Bayer BAYGn.DE of polluting the city's drainage system and the local Lower Duwamish River with toxic chemicals known as PCBs.
B
Reuters - 2 일 전

Australian judge dismisses lawsuit claiming Bayer weedkiller causes blood cancer

UPDATE 2-Australian judge dismisses lawsuit claiming Bayer weedkiller causes blood cancer Recasts and writes through with comments from judge, Bayer and plaintiffs' lawyers By Peter Hobson and Alasdair Pal CANBERRA, July 25 (Reuters) - An Australian judge on Thursday dismissed a class action lawsuit claiming Bayer's BAYGn.DE Roundup weedkiller can cause a type of blood cancer, a ruling the company said it would seek to leverage in similar cases being fought in the United States.
B
Reuters - 2 일 전

Australian judge dismisses lawsuit claiming Bayer's Roundup weedkiller causes cancer

Australian judge dismisses lawsuit claiming Bayer's Roundup weedkiller causes cancer SYDNEY, July 25 (Reuters) - An Australian judge said on Thursday it was not proven that an ingredient in Bayer's BAYGn.DE Roundup weedkiller increases the risk of cancer in users. Reporting by Alasdair Pal in Sydney Editing by Praveen Menon
B
Reuters - 2 일 전

Roche lifts 2024 profit guidance on strong drug sales

UPDATE 2-Roche lifts 2024 profit guidance on strong drug sales First-half operating profit growth beats analyst estimates Revenue from eye drug Vabysmo nearly doubles, beats estimates Expects close to 10% adjusted profit growth, up vs previous Shares traded near 1-year high earlier on Thursday Adds details on eye drug in paragraphs 5 and 7, details on CEO's strategy in last two paragraphs By Ludwig Burger FRANKFURT, July 25 (Reuters) - Roche ROG.S on Thursday raised its full-year earnings foreca
A
B
R
R
S
Reuters - 2 일 전

Australian court to rule on whether Bayer weedkiller can cause blood cancer

Australian court to rule on whether Bayer weedkiller can cause blood cancer By Peter Hobson and Alasdair Pal CANBERRA, July 25 (Reuters) - An Australian judge will rule on Thursday on whether Bayer's BAYGn.DE Roundup weedkiller can cause a type of blood cancer, a closely watched decision that follows some jury verdicts in similar U.S. cases that have found for the plaintiffs.
B
Reuters - 5 일 전

Bayer heads to trial in US antitrust lawsuit over flea, tick medication

Bayer heads to trial in US antitrust lawsuit over flea, tick medication By Mike Scarcella July 22 (Reuters) - A former unit of German life-sciences giant Bayer BAYGn.DE is squaring off in California federal court this week with a petcare startup that claims the company tried to block competition for animal tick and flea treatments. Jurors in San Jose federal court heard opening statements on Monday in the antitrust case, which was brought by Tevra Brands in 2019 against Bayer Healthcare.
B
Reuters - 1 주 전

Let the chips fall where they may

LIVE MARKETS-Let the chips fall where they may Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com LET THE CHIPS FALL WHERE THEY MAY European equities are heading for a downbeat start today, with the exception of London's FTSE 100 .FTSE , which may get a little boost from British data that showed inflation held at 2% last month.
B
H
A
E
F
U
G
Reuters - 1 주 전

Bayer eyes wider Nubeqa use on new prostate cancer trial data

UPDATE 1-Bayer eyes wider Nubeqa use on new prostate cancer trial data Rewrites throughout By Ludwig Burger FRANKFURT, July 17 (Reuters) - Bayer BAYGn.DE said on Wednesday its Nubeqa drug was shown to slow the progression of a certain type of prostate cancer in a late-stage trial, underpinning growth prospects for one of the German drugmaker's key pharmaceutical products.
B
Reuters - 1 주 전

Bayer says darolutamide shown to slow prostate cancer progression

Bayer says darolutamide shown to slow prostate cancer progression FRANKFURT, July 17 (Reuters) - Bayer BAYGn.DE said on Wednesday its drug candidate darolutamide was shown to slow the progression of certain types of prostate cancer in a late-stage trial. Bayer is working on darolutamide jointly with Filand's Orion ORNBV.HE . Reporting by Ludwig Bur
B
Reuters - 1 주 전

Orion Says Phase III Aranote Trial Of Darolutamide Meets Primary Endpoint

BRIEF-Orion Says Phase III Aranote Trial Of Darolutamide Meets Primary Endpoint July 17 (Reuters) - Orion Oyj ORNBV.HE : REG-INSIDE INFORMATION: PHASE III ARANOTE TRIAL OF DAROLUTAMIDE IN COMBINATION WITH ANDROGEN DEPRIVATION THERAPY IN MEN WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER MEETS PRIMARY ENDPOINT ORION AND BAYER'S PHASE III ARANOTE
B
Reuters - 2 주 전

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Unilever July 15 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts and 36 branch closures, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * METSO METSO.HE : The Finnis
B
B
B
B
C
I
M
N
T
T
U
V
B
U
Reuters - 2 주 전

Bayer: Askbio Receives FDA Fast Track Designation For 1005 Parkinson's Therapy

BRIEF-Bayer: Askbio Receives FDA Fast Track Designation For AB-1005 Parkinson's Therapy July 11 (Reuters) - Bayer AG BAYGn.DE : ASKBIO RECEIVES FDA FAST TRACK AND MHRA INNOVATION PASSPORT DESIGNATIONS FOR AB-1005 INVESTIGATIONAL GDNF GENE THERAPY FOR PARKINSON'S DISEASE ASKBIO IS CURRENTLY ENROLLING PATIENTS IN ITS PHASE II REGENERATE-PD TRIAL IN U
B
Reuters - 2 주 전

BASF to cease production of glufosinate-ammonium weed killer

UPDATE 2-BASF to cease production of glufosinate-ammonium weed killer Recasts first paragraph to add that BASF said it will cease production of the weed killer BERLIN, July 10 (Reuters) - BASF BASFn.DE plans to shut down production of the glufosinate-ammonium weed killer due to growing competition as well as high energy and raw materials costs, the German chemicals group said on Wednesday.
B
B
Reuters - 3 주 전

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds details on fresh job cuts July 9 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts and 36 branch closures, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * METSO METSO
B
B
B
B
C
I
M
N
T
T
U
V
B
U
Reuters - 4 주 전

Bayer And Rad AI Announce Collaboration Agreement

BRIEF-Bayer And Rad AI Announce Collaboration Agreement June 27 (Reuters) - BAYER AG BAYGn.DE : BAYER AND RAD AI ANNOUNCE COLLABORATION AGREEMENT BAYER AND RAD AI ARE ANNOUNCING A COLLABORATION TO BRING RAD AI'S CUTTING EDGE AI RADIOLOGY OPERATIONAL SOLUTIONS TO CALANTIC ™ DIGITAL SOLUTION CUSTOMERS Source text for Eikon: ID:nBw8vRJLZa Further co
B
Reuters - 4 주 전

German chemical sector employers, union agree 6.85% pay hike over 20 months

UPDATE 1-German chemical sector employers, union agree 6.85% pay hike over 20 months Adds companies, background on metalworking sector FRANKFURT, June 27 (Reuters) - Germany's BAVC chemical industry association on Thursday agreed with union IGBCE on staggered wage hikes that will give workers 6.85% higher pay over 20 months. As part of the deal, the 585,000 workers covered by the agreement will receive an additional day off per year , the union and the employers' association said in separate sta
B
B
D
Reuters - 4 주 전

Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia

Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia By Michael Erman NEW YORK, June 26 (Reuters) - A top Bayer BAYGn.DE pharmaceutical executive said on Wednesday his group will continue slashing managerial jobs this year, planning cuts in Germany, Japan, the United Kingdom, Belgium and the Netherlands as part of the company's internal reorganization.
B
R
Reuters - 1 달 전

Bayer: AskBio Starts Recruitment To Its Phase 2 Parkinson's Disease Trial

BRIEF-Bayer: AskBio Starts Recruitment To Its Phase 2 Parkinson's Disease Trial June 25 (Reuters) - BAYER AG BAYGn.DE : ASKBIO INITIATES RECRUITMENT TO ITS PHASE 2 PARKINSON'S DISEASE TRIAL Further company coverage: [BAYGn.DE] (Gdansk Newsroom)
B
Reuters - 1 달 전

Bayer looks to AI to combat herbicide resistance faster

Bayer looks to AI to combat herbicide resistance faster By Renee Hickman CHICAGO, June 18 (Reuters) - Bayer's crop science division is increasingly turning to artificial intelligence in its battle against crop killing weeds, the company told Reuters. Weeds are growing resistant to the herbicides already on the market, and agribusiness companies like Bayer are in a desperate search for new modes of action to help farmers kill them.
B

조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.